No internet connection — showing the saved version of the page.

Revvity Inc.

USUSD
← to the screener

Revvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
revvity.com
Investor relations
ir.revvity.com/home/default.aspx
Sector
Industrials · Biotechnology: Laboratory Analytical Instruments
Headquarters
Waltham, United States
CEO
Prahlad R. Singh
Employees
11 000
Shares outstanding
111.59 M as of 2026-08-06
Free float
102.49 M
Market cap
16.63 B USD
Insiders
0.26%
Institutions
96.55%
Industry (SIC)
Laboratory Analytical Instruments
Legal form
ZJTK
LEI
549300IKL1SDPFI7N655
Payout ratio
13.4%
FCF
558 M USD
Payout / FCF
6%
Debt
3.21 B USD
3.9 y of FCF
Dividend streak
43 y
Earnings, FCF and dividends paid — for the 12 months to 05.07.2026 (the company's latest report).
NAV
64.78 USD · P/NAV 2.34
Balance sheet date05.07.2026
Assets12.0 B USD
− Liabilities4.82 B USD
= NAV (equity of the company's shareholders)7.23 B USD
− Goodwill6.61 B USD
− Intangible assets2.22 B USD
= Tangible NAV−1.60 B USD
Shares111 584 000
NAV per share64.78 USD
Tangible NAV per share−14.37 USD
Share price (0KHE)151.34 USD
P/NAV2.34
NAV history
Balance sheet dateNAVNAV per share
05.07.20267.23 B USD64.78 USD
05.04.20267.18 B USD64.34 USD
28.12.20257.25 B USD64.57 USD
28.09.20257.38 B USD64.68 USD
29.06.20257.56 B USD64.95 USD
30.03.20257.64 B USD63.96 USD
29.12.20247.67 B USD63.55 USD
29.09.20247.92 B USD64.88 USD
Description

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksRVTY primaryUSD150.94 -1.11%common stock
LSE London Stock Exchange0KHE IOBUSD151.34 +0.00%common stock
XETRA XetraPKN secondaryEUR136.5 +0.18%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Next ex-date: 2026-10-23 · 0.07 USD (US:RVTY)
Per year, US:RVTY: 0.28 USD (4 paym.)

Revvity Inc. (RVTY) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 0.28 USD per share (payments: 4). That is about 0.19% of the current share price. The next ex-dividend date is 23.10.2026: 0.07 USD per share, paid on 13.11.2026. Uninterrupted dividend history: 43 years.

Ex-datePaymentAmount%TypeTicker
2026-10-23 announced2026-11-130.0700 USD0.0/0.2 %quarterlyUS:RVTY
2026-07-172026-08-070.0700 USD0.1/0.3 %quarterlyUS:RVTY
2026-04-172026-05-080.0700 USD0.1/0.3 %quarterlyUS:RVTY
2026-01-162026-02-060.0700 USD0.1/0.2 %quarterlyUS:RVTY
2025-10-172025-11-070.0700 USD0.1/0.3 %quarterlyUS:RVTY
2025-07-182025-08-080.0700 USD0.1/0.3 %quarterlyUS:RVTY
2025-04-172025-05-090.0700 USD0.1/0.3 %quarterlyUS:RVTY
2025-01-172025-02-070.0700 USD0.1/0.2 %quarterlyUS:RVTY
2024-10-182024-11-080.0700 USD0.1/0.2 %quarterlyUS:RVTY
2024-07-192024-08-090.0700 USD0.0/0.2 %quarterlyUS:RVTY
2024-04-182024-05-100.0700 USD0.0/≈0.2 %quarterlyUS:RVTY
2024-01-182024-02-090.0700 USD0.0/≈0.2 %quarterlyUS:RVTY
2023-10-192023-11-100.0700 USD0.0/≈0.2 %quarterlyUS:RVTY

Top holders

HolderStakeSharesReport date
T. Rowe Price Investment…16.37%18.26 M2026-06-30
T. ROWE PRICE CAPITAL AP…10.2%11.38 M2026-06-30
Jupiter Topco LLC7.74%8.64 M2026-06-30
Edgepoint Investment Gro…7.66%8.54 M2026-06-30
Blackrock Inc.6.86%7.66 M2026-06-30
Vanguard Capital Managem…6.54%7.3 M2026-06-30
JANUS INVESTMENT FUND-Ja…5.15%5.75 M2026-06-30
Price (T.Rowe) Associate…4.96%5.53 M2026-06-30
Vanguard Portfolio Manag…4.28%4.77 M2026-06-30
State Street Corporation3.89%4.34 M2026-06-30
Victory Capital Manageme…3.27%3.65 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.55 M2026-06-30
Dimensional Fund Advisor…3.07%3.43 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%2.89 M2026-06-30
-Price (T.Rowe) U.S. Val…2.41%2.69 M2026-06-30
TR PRICE-Price (T.Rowe)…2.41%2.69 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%2.56 M2026-06-30
JNL Series Trust-JNL/T.…2.27%2.53 M2026-06-30
Victory Portfolios-Victo…2.12%2.37 M2026-06-30
T. Rowe Price Value Fund…1.93%2.16 M2026-06-30
Invesco Exchange-Traded…1.67%1.87 M2026-08-31
SINGH PRAHLAD R (Chief E…≈0.09%105 6762026-08-13
GOLDBERG JOEL S (General…≈0.09%105 2232026-08-14
BARRETT PETER (Director)≈0.03%28 2932026-05-07
WITNEY FRANKLIN R. PH.D.…≈0.02%23 3542026-05-07
CHAPIN SAMUEL R. (Direct…≈0.02%22 6762026-05-07
VICTOR MIRIAME (Officer)≈0.02%18 1222026-02-24
WITZ PASCALE (Director)≈0.01%15 9852026-05-07
KRAKOWIAK MAXWELL (Chief…≈0.01%14 7812026-09-21
MICHAS ALEXANDROS P (Dir…——2026-08-25
MICHAS ALEXIS P (Directo…——2025-08-27